Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2020 Filed Feb 18, 2020 21:29 UTC |
CONNAUGHTON JOHNDirector
|
SaleCommon Stock | 703,828 | $164.30 | $115,638,940.40 |
DisclosureSEC source: 0000899243-20-004885 · doc4.xml · nonDerivative · entry 1 CONNAUGHTON JOHN · CIK 0001213395 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 685,712 F1 · ownership.nature: Represents shares of common stock held directly by Bain Capital Integral Investors 2008, L.P. ("Integral 2008"), BCIP TCV, LLC ("BCIP TCV") and BCIP Associates-G ("BCIP-G" and, collectively, the "Bain Capital Entities"). F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the ultimate general partner of Integral 2008 and governs the investment strategy and decision-making process with respect to investments held by each of BCIP TCV and BCIP-G. John Connaughton is a Managing Director of BCI. By virtue of the relationships described in this footnote, Mr. Connaughton may be deemed to share voting and dispositive power with respect to all of the shares of common stock held by the Bain Capital Entities. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:13 UTC |
McDonnell Michael R.EVP and CFO
|
GrantStock Appreciation Right · Derivative | 23,897 | $0.00 Strike: $161.70 | $0.00 |
DisclosureSEC source: 0001478242-20-000012 · edgar.xml · derivative · entry 3 MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,897 Underlying: Common Stock · 23,897 shares Expires 2030-02-11 F2 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:13 UTC |
McDonnell Michael R.EVP and CFO
|
Tax withholdingCommon Stock | 5,366 | $161.70 | $867,682.20 |
DisclosureSEC source: 0001478242-20-000012 · edgar.xml · nonDerivative · entry 2 MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,728 Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:13 UTC |
McDonnell Michael R.EVP and CFO
|
GrantCommon Stock | 12,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-20-000012 · edgar.xml · nonDerivative · entry 1 MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,094 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 2, 2017. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 11, 2020. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:11 UTC |
STAUB W RICHARDSee Remarks
|
GrantStock Appreciation Right · Derivative | 22,404 | $0.00 Strike: $161.70 | $0.00 |
DisclosureSEC source: 0001478242-20-000011 · edgar.xml · derivative · entry 3 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,404 Underlying: Common Stock · 22,404 shares Expires 2030-02-11 F2 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:11 UTC |
STAUB W RICHARDSee Remarks
|
Tax withholdingCommon Stock | 3,081 | $161.70 | $498,197.70 |
DisclosureSEC source: 0001478242-20-000011 · edgar.xml · nonDerivative · entry 2 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,729 Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:11 UTC |
STAUB W RICHARDSee Remarks
|
GrantCommon Stock | 8,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-20-000011 · edgar.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,810 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 2, 2017. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 11, 2020. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:19 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantStock Appreciation Right · Derivative | 224,040 | $0.00 Strike: $161.70 | $0.00 |
DisclosureSEC source: 0001478242-20-000014 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,040 Underlying: Common Stock · 224,040 shares Expires 2030-02-11 F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:19 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 37,401 | $161.70 | $6,047,741.70 |
DisclosureSEC source: 0001478242-20-000014 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652,035 Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:19 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 76,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-20-000014 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 689,436 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock granted on February 2, 2017. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 11, 2020. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:15 UTC |
Knightly Kevin CSee Remarks
|
GrantStock Appreciation Right · Derivative | 14,936 | $0.00 Strike: $161.70 | $0.00 |
DisclosureSEC source: 0001478242-20-000013 · edgar.xml · derivative · entry 3 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,936 Underlying: Common Stock · 14,936 shares Expires 2030-02-11 F2 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:15 UTC |
Knightly Kevin CSee Remarks
|
Tax withholdingCommon Stock | 3,222 | $161.70 | $520,997.40 |
DisclosureSEC source: 0001478242-20-000013 · edgar.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,879 Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:15 UTC |
Knightly Kevin CSee Remarks
|
GrantCommon Stock | 8,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-20-000013 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,101 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 2, 2017. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 11, 2020. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:09 UTC |
Korakis Emmanuel NSr. Vice President, Controller
|
GrantStock Appreciation Right · Derivative | 5,974 | $0.00 Strike: $161.70 | $0.00 |
DisclosureSEC source: 0001478242-20-000010 · edgar.xml · derivative · entry 1 Korakis Emmanuel N · CIK 0001449366 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,974 Underlying: Common Stock · 5,974 shares Expires 2030-02-11 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:07 UTC |
Sherbet EricSee Remarks
|
GrantStock Appreciation Right · Derivative | 22,404 | $0.00 Strike: $161.70 | $0.00 |
DisclosureSEC source: 0001478242-20-000009 · edgar.xml · derivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,404 Underlying: Common Stock · 22,404 shares Expires 2030-02-11 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 4, 2021 22:23 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 178 | $161.70 | $28,782.60 |
DisclosureSEC source: 0001478242-21-000005 · wf-form5_161247740132282.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993 Underlying: Common Stock · 178 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 02, 2020 Filed Feb 4, 2020 22:03 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 30,201 | $155.25 | $4,688,705.25 |
DisclosureSEC source: 0001478242-20-000008 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,062 Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 22:02 UTC |
EVANISKO MICHAEL JDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,250 | $0.00 Strike: $23.70 | $0.00 |
DisclosureSEC source: 0001478242-20-000007 · edgar.xml · derivative · entry 3 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2020-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 22:02 UTC |
EVANISKO MICHAEL JDirector
|
SaleCommon Stock | 6,250 | $155.19 | $969,937.50 |
DisclosureSEC source: 0001478242-20-000007 · edgar.xml · nonDerivative · entry 2 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 5,250 F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 19, 2019. F3 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $154.55 to $156.63 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 22:02 UTC |
EVANISKO MICHAEL JDirector
|
Exercise / conversionCommon Stock | 6,250 | $23.70 | $148,125.00 |
DisclosureSEC source: 0001478242-20-000007 · edgar.xml · nonDerivative · entry 1 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 11,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 22:00 UTC |
EVANISKO MICHAEL JDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,250 | $0.00 Strike: $23.70 | $0.00 |
DisclosureSEC source: 0001478242-20-000006 · edgar.xml · derivative · entry 5 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 6,250 Underlying: Common Stock · 2,250 shares Expires 2020-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 22:00 UTC |
EVANISKO MICHAEL JDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $18.40 | $0.00 |
DisclosureSEC source: 0001478242-20-000006 · edgar.xml · derivative · entry 4 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2020-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 22:00 UTC |
EVANISKO MICHAEL JDirector
|
SaleCommon Stock | 6,250 | $159.07 | $994,187.50 |
DisclosureSEC source: 0001478242-20-000006 · edgar.xml · nonDerivative · entry 3 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 5,250 F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 19, 2019. F3 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $157.88 to $161.62 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 22:00 UTC |
EVANISKO MICHAEL JDirector
|
Exercise / conversionCommon Stock | 2,250 | $23.70 | $53,325.00 |
DisclosureSEC source: 0001478242-20-000006 · edgar.xml · nonDerivative · entry 2 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 11,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 22:00 UTC |
EVANISKO MICHAEL JDirector
|
Exercise / conversionCommon Stock | 4,000 | $18.40 | $73,600.00 |
DisclosureSEC source: 0001478242-20-000006 · edgar.xml · nonDerivative · entry 1 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 9,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 22:00 UTC |
EVANISKO MICHAEL JDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,250 | $0.00 Strike: $18.40 | $0.00 |
DisclosureSEC source: 0001478242-20-000004 · edgar.xml · derivative · entry 3 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 4,000 Underlying: Common Stock · 6,250 shares Expires 2020-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 22:00 UTC |
EVANISKO MICHAEL JDirector
|
SaleCommon Stock | 6,250 | $160.76 | $1,004,750.00 |
DisclosureSEC source: 0001478242-20-000004 · edgar.xml · nonDerivative · entry 2 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 5,250 F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 19, 2019. F3 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $159.49 to $161.45 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 22:00 UTC |
EVANISKO MICHAEL JDirector
|
Exercise / conversionCommon Stock | 6,250 | $18.40 | $115,000.00 |
DisclosureSEC source: 0001478242-20-000004 · edgar.xml · nonDerivative · entry 1 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 11,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:56 UTC |
EVANISKO MICHAEL JDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,250 | $0.00 Strike: $18.40 | $0.00 |
DisclosureSEC source: 0001478242-20-000003 · edgar.xml · derivative · entry 3 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 10,250 Underlying: Common Stock · 6,250 shares Expires 2020-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:56 UTC |
EVANISKO MICHAEL JDirector
|
SaleCommon Stock | 6,250 | $160.08 | $1,000,500.00 |
DisclosureSEC source: 0001478242-20-000003 · edgar.xml · nonDerivative · entry 2 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 5,250 F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 19, 2019. F3 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $159.60 to $160.72 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:56 UTC |
EVANISKO MICHAEL JDirector
|
Exercise / conversionCommon Stock | 6,250 | $18.40 | $115,000.00 |
DisclosureSEC source: 0001478242-20-000003 · edgar.xml · nonDerivative · entry 1 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 11,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:05 UTC |
McDonnell Michael R.EVP and CFO
|
SaleCommon Stock | 12,000 | $155.07 | $1,860,840.00 |
DisclosureSEC source: 0001478242-20-000002 · edgar.xml · nonDerivative · entry 1 MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,366 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 23, 2019. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $155.00 to $155.10 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 22:03 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 86,874 | $154.51 | $13,422,901.74 |
DisclosureSEC source: 0001478242-20-000001 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,263 Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:33 UTC |
LEONARD JOHN MDirector
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $64.52 | $0.00 |
DisclosureSEC source: 0001478242-19-000043 · edgar.xml · derivative · entry 8 LEONARD JOHN M. · CIK 0001563584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2026-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:33 UTC |
LEONARD JOHN MDirector
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,600 | $0.00 Strike: $64.86 | $0.00 |
DisclosureSEC source: 0001478242-19-000043 · edgar.xml · derivative · entry 7 LEONARD JOHN M. · CIK 0001563584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,600 shares Expires 2025-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:33 UTC |
LEONARD JOHN MDirector
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,600 | $0.00 Strike: $64.93 | $0.00 |
DisclosureSEC source: 0001478242-19-000043 · edgar.xml · derivative · entry 6 LEONARD JOHN M. · CIK 0001563584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,600 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:33 UTC |
LEONARD JOHN MDirector
|
SaleCommon Stock | 10,100 | $155.00 | $1,565,500.00 |
DisclosureSEC source: 0001478242-19-000043 · edgar.xml · nonDerivative · entry 5 LEONARD JOHN M. · CIK 0001563584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,252 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:33 UTC |
LEONARD JOHN MDirector
|
SaleCommon Stock | 10,100 | $151.00 | $1,525,100.00 |
DisclosureSEC source: 0001478242-19-000043 · edgar.xml · nonDerivative · entry 4 LEONARD JOHN M. · CIK 0001563584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,352 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:33 UTC |
LEONARD JOHN MDirector
|
Exercise / conversionCommon Stock | 7,000 | $64.52 | $451,640.00 |
DisclosureSEC source: 0001478242-19-000043 · edgar.xml · nonDerivative · entry 3 LEONARD JOHN M. · CIK 0001563584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:33 UTC |
LEONARD JOHN MDirector
|
Exercise / conversionCommon Stock | 6,600 | $64.86 | $428,076.00 |
DisclosureSEC source: 0001478242-19-000043 · edgar.xml · nonDerivative · entry 2 LEONARD JOHN M. · CIK 0001563584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:33 UTC |
LEONARD JOHN MDirector
|
Exercise / conversionCommon Stock | 6,600 | $64.93 | $428,538.00 |
DisclosureSEC source: 0001478242-19-000043 · edgar.xml · nonDerivative · entry 1 LEONARD JOHN M. · CIK 0001563584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2019 Filed Jan 21, 2020 22:02 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 201 | $143.57 | $28,857.57 |
DisclosureSEC source: 0001478242-20-000005 · edgar.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 815 Underlying: Common Stock · 201 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:08 UTC |
STAUB W RICHARDSee Remarks
|
Tax withholdingCommon Stock | 1,365 | $149.38 | $203,903.70 |
DisclosureSEC source: 0001478242-19-000041 · edgar.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,900 Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:04 UTC |
Knightly Kevin CSee Remarks
|
Tax withholdingCommon Stock | 1,893 | $149.38 | $282,776.34 |
DisclosureSEC source: 0001478242-19-000040 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,191 Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 17:00 UTC |
TPG Advisors VI, Inc.Director
TPG Advisors V, Inc.Director
TPG Biotech Advisors, Inc.Director
BONDERMAN DAVIDDirector
COULTER JAMES GDirector
|
SaleCommon Stock | 2,616,028 | $156.85 | $410,323,991.80 |
DisclosureSEC source: 0000903423-19-000311 · iqvia.xml · nonDerivative · entry 1 TPG Group Holdings (SBS) Advisors, Inc. · CIK 0001495741 · Director TPG Advisors VI, Inc. · CIK 0001433038 · Director TPG Advisors V, Inc. · CIK 0001425876 · Director TPG Biotech Advisors, Inc. · CIK 0001666545 · Director BONDERMAN DAVID · CIK 0000860866 · Director COULTER JAMES G · CIK 0001099776 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 5,915,223 F1 · ownership.nature: David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. ("Group Advisors"), (ii) TPG Advisors VI, Inc. ("Advisors VI"), (iii) TPG Advisors V, Inc. ("Advisors V") and (iv) TPG Biotech Advisors, Inc. ("Biotech Advisors" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the "Reporting Persons"). F2 · ownership.nature: Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 2,115,281 shares of Common Stock ("Common Stock") of IQVIA Holdings Inc. (the "Issuer"), (ii) TPG FOF V-A, L.P., which directly holds 5,534 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 4,462 shares of Common Stock. F3 · ownership.nature: TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 2,116,908 shares of Common Stock. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 87,340 shares of Common Stock. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 8,368 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 727,835 shares of Common Stock. F4 · ownership.nature: Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 807,253 shares of Common Stock. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the "TPG Funds"), which directly holds 42,242 shares of Common Stock. F5 · ownership.nature: Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any. F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 20:28 UTC |
CONNAUGHTON JOHNDirector
|
GiftCommon Stock | 4,679 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-021581 · doc4.xml · nonDerivative · entry 3 CONNAUGHTON JOHN · CIK 0001213395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 20:28 UTC |
CONNAUGHTON JOHNDirector
|
OtherCommon Stock | 52,909 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-021581 · doc4.xml · nonDerivative · entry 2 CONNAUGHTON JOHN · CIK 0001213395 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,389,540 F3 · kind: On August 8, 2019, certain of the Bain Capital Entities distributed 52,909 shares of common stock to one or more members or partners of the Bain Capital Entities, including 4,679 shares of common stock to Mr. Connaughton, in connection with certain charitable gifts made by such members or partners. F1 · ownership.nature: Represents shares of common stock held directly by Bain Capital Integral Investors 2008, L.P. ("Integral 2008"), BCIP TCV, LLC ("BCIP TCV") and BCIP Associates-G ("BCIP-G" and, collectively, the "Bain Capital Entities"). F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the ultimate general partner of Integral 2008 and governs the investment strategy and decision-making process with respect to investments held by each of BCIP TCV and BCIP-G. John Connaughton is a Managing Director of BCI. By virtue of the relationships described in this footnote, Mr. Connaughton may be deemed to share voting and dispositive power with respect to all of the shares of common stock held by the Bain Capital Entities. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 20:28 UTC |
CONNAUGHTON JOHNDirector
|
SaleCommon Stock | 573,085 | $156.85 | $89,888,382.25 |
DisclosureSEC source: 0000899243-19-021581 · doc4.xml · nonDerivative · entry 1 CONNAUGHTON JOHN · CIK 0001213395 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,442,449 F1 · ownership.nature: Represents shares of common stock held directly by Bain Capital Integral Investors 2008, L.P. ("Integral 2008"), BCIP TCV, LLC ("BCIP TCV") and BCIP Associates-G ("BCIP-G" and, collectively, the "Bain Capital Entities"). F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the ultimate general partner of Integral 2008 and governs the investment strategy and decision-making process with respect to investments held by each of BCIP TCV and BCIP-G. John Connaughton is a Managing Director of BCI. By virtue of the relationships described in this footnote, Mr. Connaughton may be deemed to share voting and dispositive power with respect to all of the shares of common stock held by the Bain Capital Entities. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 21:05 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 4,278 | $158.50 | $678,063.00 |
DisclosureSEC source: 0001478242-19-000039 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,084 Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:00 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 6,945 | $158.53 | $1,100,990.85 |
DisclosureSEC source: 0001478242-19-000037 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,362 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $158.45 to $158.55 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.